The nation of Zimbabwe has declined a major US healthcare agreement worth 367 million US dollars (£272m) over five years because of the United States' insistence on confidential information.
This move was revealed after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson later explained that the United States was seeking biological samples for scientific study and profit while was not willing to guarantee the benefits from future vaccines.
"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged further negotiations to secure a deal suitable to all parties so the country's critical HIV programme can be sustained.
Broader Implications
This development comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
According to reports, Sixteen nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this collaboration might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," he stated.
"Effectively, our nation would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our citizens if a future health crisis emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were disrupting structures previously set up via the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to deal with potential pandemics.
"This system is designed to ensure that when a country provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage further discussions with our US partners on how subsequent collaboration could be designed in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but recommended that negotiations need to persist since a large portion of the country's HIV programmes relied on foreign aid.
"Where technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," it commented.
The situation emphasises the ongoing tensions between receiving much-needed international aid and safeguarding national sovereignty in an increasingly data-driven world.